OBJECTIVE: To assess the associations of medial temporal lobe atrophy (MTA) and white matter hyperintensities (WMH) with cognitive function in a large group of independently functioning elderly people. METHODS: Data were drawn from the multicentre, multinational leukoaraiosis and disability (LADIS) project which is studying prospectively the role of WMH as an independent predictor of the transition to disability in non-disabled elderly people. In all, 639 participants were enrolled in the LADIS study. For the present analysis, data on 581 subjects were available. Cognitive function was assessed by the mini-mental state examination (MMSE). Visual ratings of WMH and MTA were undertaken on magnetic resonance images (MRI). RESULTS: The presence of either severe WMH or MTA was associated with a modest but non-significant increase in frequency of mild cognitive deficits (severe WMH: odds ratio (OR) = 1.9 (95% confidence interval (CI), 1.0 to 3.7); MTA present: OR = 1.5 (95% CI, 0.8 to 2.8)). However, subjects with the combination of MTA and severe WMH had a more than fourfold increase in frequency of mild cognitive deficits (OR = 4.1 (95% CI, 2.3 to 7.4)). Analysis of variance with post hoc Bonferroni t tests showed that subjects with both MTA and severe WMH performed worse on MMSE than those with either no MRI abnormality or a single MRI abnormality (p<0.05). CONCLUSIONS: These results provide further evidence for the combined involvement of both Alzheimer type pathology and vascular pathology in the earliest stages of cognitive decline and suggest an additive effect of WMH and MTA.
OBJECTIVE: To assess the associations of medial temporal lobe atrophy (MTA) and white matter hyperintensities (WMH) with cognitive function in a large group of independently functioning elderly people. METHODS: Data were drawn from the multicentre, multinational leukoaraiosis and disability (LADIS) project which is studying prospectively the role of WMH as an independent predictor of the transition to disability in non-disabled elderly people. In all, 639 participants were enrolled in the LADIS study. For the present analysis, data on 581 subjects were available. Cognitive function was assessed by the mini-mental state examination (MMSE). Visual ratings of WMH and MTA were undertaken on magnetic resonance images (MRI). RESULTS: The presence of either severe WMH or MTA was associated with a modest but non-significant increase in frequency of mild cognitive deficits (severe WMH: odds ratio (OR) = 1.9 (95% confidence interval (CI), 1.0 to 3.7); MTA present: OR = 1.5 (95% CI, 0.8 to 2.8)). However, subjects with the combination of MTA and severe WMH had a more than fourfold increase in frequency of mild cognitive deficits (OR = 4.1 (95% CI, 2.3 to 7.4)). Analysis of variance with post hoc Bonferroni t tests showed that subjects with both MTA and severe WMH performed worse on MMSE than those with either no MRI abnormality or a single MRI abnormality (p<0.05). CONCLUSIONS: These results provide further evidence for the combined involvement of both Alzheimer type pathology and vascular pathology in the earliest stages of cognitive decline and suggest an additive effect of WMH and MTA.
Authors: R C Petersen; C R Jack; Y C Xu; S C Waring; P C O'Brien; G E Smith; R J Ivnik; E G Tangalos; B F Boeve; E Kokmen Journal: Neurology Date: 2000-02-08 Impact factor: 9.910
Authors: Leonardo Pantoni; Anna Maria Basile; Giovanni Pracucci; Kjell Asplund; Julien Bogousslavsky; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; John O'brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari Journal: Neuroepidemiology Date: 2005 Impact factor: 3.282
Authors: W M van der Flier; H A M Middelkoop; A W E Weverling-Rijnsburger; F Admiraal-Behloul; A Spilt; E L E M Bollen; R G J Westendorp; M A van Buchem Journal: Neurology Date: 2004-05-25 Impact factor: 9.910
Authors: Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon Journal: Clin Neuropsychol Date: 2009-08 Impact factor: 3.535
Authors: Mohamad Habes; Guray Erus; Jon B Toledo; Tianhao Zhang; Nick Bryan; Lenore J Launer; Yves Rosseel; Deborah Janowitz; Jimit Doshi; Sandra Van der Auwera; Bettina von Sarnowski; Katrin Hegenscheid; Norbert Hosten; Georg Homuth; Henry Völzke; Ulf Schminke; Wolfgang Hoffmann; Hans J Grabe; Christos Davatzikos Journal: Brain Date: 2016-02-24 Impact factor: 13.501
Authors: Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson Journal: Nat Rev Neurol Date: 2010-02 Impact factor: 42.937
Authors: Nienke Legdeur; Pieter Jelle Visser; Davis C Woodworth; Majon Muller; Evan Fletcher; Pauline Maillard; Philip Scheltens; Charles DeCarli; Claudia H Kawas; María M Corrada Journal: J Am Geriatr Soc Date: 2019-06-06 Impact factor: 5.562
Authors: Reinhold Schmidt; Anja Grazer; Christian Enzinger; Stefan Ropele; Nina Homayoon; Aga Pluta-Fuerst; Petra Schwingenschuh; Petra Katschnig; Margherita Cavalieri; Helena Schmidt; Christian Langkammer; Franz Ebner; Franz Fazekas Journal: J Neural Transm (Vienna) Date: 2011-02-22 Impact factor: 3.575
Authors: Noll L Campbell; Fred Unverzagt; Michael A LaMantia; Babar A Khan; Malaz A Boustani Journal: Clin Geriatr Med Date: 2013-11 Impact factor: 3.076